<mets:mets OBJID="eprint_45" LABEL="Eprints Item" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mets:metsHdr CREATEDATE="2026-07-04T18:49:00Z"><mets:agent ROLE="CUSTODIAN" TYPE="ORGANIZATION"><mets:name>Repositori BKPK</mets:name></mets:agent></mets:metsHdr><mets:dmdSec ID="DMD_eprint_45_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:titleInfo><mods:title>Therapy of Uncomplicated Falciparum  Malaria : A Randomized Trial Comparing Artesunate Plus Sulfadoxine-Pyrimethamine Versus Sulfadoxine-Pyrimethamine Alone in Irian Jaya, Indonesia</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Emiliana</mods:namePart><mods:namePart type="family">Tjitra</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Combining artesunate with existing antimalaria drugs may improve cure rates, delay emergence of resistance, and reduce transmisison. We performend a randomized comparative trial to quantify the effect  of adding artesunate to sulfadoxine-pyrimethamine in  the treatment of uncomplicated falciparum malaria in Indonesia.   Using a modified 1997 World Health Organization protocol for assessment of therapeutic efficacy of antimalaria drugs, 105 patients (stratified by age/ethnic group) were randomized: 53 received artesunate orally 4 mg/kg of body weight, a single daily dose for three days, plus sulfadoxine-pyrimethamine orally (1.25 mg of pyrimethamine/kg of body weight), a single dose on day 0 and 52 patients received sulfadoxine- pyrimethamine alone. Six from the combination group were withdrawn from analysis, as were six of the sulfadoxine-pyrimethamine group.   Treatment failure rates on day 14 were 0%in the artesunate plus sulfadoxine-pyrimethamine group and 8.7% in the sulfadoxine-pyrimethamine group (P=0.12). Treatment failure rates on day 28 were 4.4% and 15.2%, respectively (P=0.16). Relative risk of treatment failure at 28 day was 0.3 (95% confidence inteval [CI]=0.1&amp;#8211;1.3). Mean fever clearance time (1.3 versus 1.7 days) and mean parasite clearance time (1.4 versus 2.0 days) were both faster in the artesunate plus sulfadoxine-pyrimethamine group than in the  sulfadoxine-pyrimethamine group ( P=0.08 and P &lt; 0.0001, respectively). Only 20 (39.2) of 51 patients  treated with artesunate plus sulfadoxine-pyrimethamine were still parasitemic on day 1 compared with 45 (86,5%) of 52 patients treated with sulfadoxine-pyrimethamine alone  (P = 0.000001, relative risk [RR]=0.4,95% CI=0.3-0.6). Gametocyte carriage was  lower following artesunate plus sulfadoxine-pyrimethamine than following sulfadoxine-pyrimethamine  (RR=0.5, 95% CI=0.2-1.0 on day 7 and RR = 0.5, 95% CI=0.2-1.1 on day 14 ).   Mild diarrhea, rash and itching resolved without treatment. Combined artesunate plus sulfadoxine- pyrimethamine resulted in more rapid fever and parasites clearance, was well tolerated, reduced risk of treatment failure, and lowered gametocyte carriage.</mods:abstract><mods:classification authority="lcc">WC 680-950 Tropical and Parasitic Diseases</mods:classification><mods:originInfo><mods:dateIssued encoding="iso8601">2001</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Pusat Penelitian dan Pengembangan Pemberantasan Penyakit</mods:publisher></mods:originInfo><mods:genre>Monograph</mods:genre></mets:xmlData></mets:mdWrap></mets:dmdSec><mets:amdSec ID="TMD_eprint_45"><mets:rightsMD ID="rights_eprint_45_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:useAndReproduction>
<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by its own author:</strong>
In self-archiving this collection of files and associated bibliographic
metadata, I grant Repositori BKPK the right to store
them and to make them permanently available publicly for free on-line.
I declare that this material is my own intellectual property and I
understand that Repositori BKPK does not assume any
responsibility if there is any breach of copyright in distributing these
files or metadata. (All authors are urged to prominently assert their
copyright on the title page of their work.)</p>

<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by someone other than its
author:</strong> I hereby declare that the collection of files and
associated bibliographic metadata that I am archiving at
Repositori BKPK is in the public domain. If this is
not the case, I accept full responsibility for any breach of copyright
that distributing these files or metadata may entail.</p>

<p xmlns="http://www.w3.org/1999/xhtml">Clicking on the <em>Deposit Item Now</em> button indicates your agreement to these
terms.</p>
    </mods:useAndReproduction></mets:xmlData></mets:mdWrap></mets:rightsMD></mets:amdSec><mets:fileSec></mets:fileSec><mets:structMap><mets:div DMDID="DMD_eprint_45_mods" ADMID="TMD_eprint_45"></mets:div></mets:structMap></mets:mets>